Physicians' Academy for Cardiovascular Education

Clinical dialogue: CV risk in diabetes

Listen to the podcast
15' education - June 22, 2022 - Prof. Nikolaus Marx, MD (Aachen, Germany) and prof. Michael Lehrke, MD (Aachen, Germany)

Video navigation menu

  • Case presentation 00:30
  • Treatment plan (part 1 of 2) 04:16
  • Cardiovascular trials in diabetes 08:20
  • ESC guidelines for patients with diabetes and ASCVD 10:49
  • Meta-analysis of GLP-1RA in T2DM 11:51
  • Treatment plan (part 2 of 2). 16:04


Show transcript


Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.

Prof. Michael Lehrke, Department of Internal Medicine I, University Hospital Aachen, Germany.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk.


This educational activity is intended for an international audience of non-US and non-UK HCPs

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Sorry, this content is unavailable in your country.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: